Building on a unique concept of targeting intracellular oncoproteins with antibody therapies,13 a humanized PRL3 antibody (PRL3-zumab; immunoglobulin G1 [IgG1]) was developed and tested on a variety of human cancers using animal models.14 The gene discussed is PTP4A3; the disease is cancer.